Skip to main content
. Author manuscript; available in PMC: 2015 Aug 26.
Published in final edited form as: J Clin Pathol. 2014 Jun 5;67(8):690–696. doi: 10.1136/jclinpath-2013-202161

Table 5.

AXL immunohistochemical expression compared with clinicopathologic variables for patients with triple-negative tumours

Characteristic (n=128) Number Axl H-Score median (min, max) p Value
Age (mean years±SD) 56±14.3
Stage 0.175
 I 65 15 (0, 285)
 II 54 35 (0, 300)
 III 9 60 (0, 300)
Tumour size 0.997
 T1 84 15 (0, 300)
 T2 41 30 (0, 300)
 T3 3 60 (30, 80)
Node status 0.011
 N0 96 20 (0, 285)
 N1 23 80 (0, 300)
 N2 4 137.5 (10, 300)
 N3 5 10 (0, 140)
Histologic grade 0.784
 1 2 40 (0, 80)
 2 17 10 (0, 210)
 3 107 20 (0, 300)
 ILC 2 120 (0, 240)
Lymphovascular invasion 0.026
 Present 30 40 (0, 270)
 Absent 98 17.5 (0, 300)

ILC, invasive lobular carcinoma.